Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions-Reference-Cited by-同舟云学术

Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions

Published:2018-12 Issue: Volume:132 Page:169-179
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Riess Hanno,Prandoni Paolo,Harder Sebastian,Kreher Stephan,Bauersachs Rupert

Funder

Bayer AG

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference75 articles.

1. Subgroup analysis of patients with cancer in XALIA: a noninterventional study of rivaroxaban versus standard anticoagulation for VTE;Ageno;TH Open,2017

2. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial;Agnelli;J. Thromb. Haemost.,2015

3. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer;Akl;Cochrane Database Syst. Rev.,2014

4. Patient-Centered Outcomes Research Institute. Direct Oral Anticoagulants Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS);Alliance Foundation Trials LLC,2018

5. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition);Ansell;Chest,2008

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.);Hämostaseologie;2024-07-15

2. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database;Cardiovascular Drugs and Therapy;2024-06-07

3. Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline;Hämostaseologie;2023-11-22

4. The S2k guideline on the diagnosis and treatment of venous thrombosis and pulmonary embolism;Vasa;2023-10-01

5. Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach;Journal of Thrombosis and Thrombolysis;2023-08-10